Rate this app:

More details

Add your questions or answers

Q: How to get the best score?

Q: What is your favourite trick in this game/app?

Q: What is your strategy?

CTAD 2019 Gameplay, Trailers and Related Videos

Watch C++Now 2019: Timur Doumler “Better CTAD for C++20” video.

Watch CppCon 2018: Stephan T. Lavavej “Class Template Argument Deduction for Everyone” video.

Watch CppCon 2018: Timur Doumler “Class template argument deduction in C++17” video.

Watch C++Now 2019: Odin Holmes “Tacit DSL All the Things” video.

Watch C++Now 2019: Odin Holmes “Hey C, This Is What Performance Looks like" video.

Watch CppCon 2019: Timur Doumler “Type punning in modern C++” video.

Watch UNECTAD SAUDI 08 07 2019 video.

Watch Tuesday, March 5, 2019 video.

Watch C++Now 2019: Jan Wilmans “Debugview++” video.

Watch Tuesday, March 19, 2019 video.

About the application:

The development of the next generation of Alzheimer’s illness treatments is among the most necessary health needs worldwide, but presents large challenges. The goal of the meeting is to bring together today’s worldwide leaders in the treatment of Alzheimer’s illness to discuss fresh results, candidate therapeutics, and methodological problems necessary to the development of the next generation of Alzheimer’s illness treatments. Clinical trial squads from worldwide centers will report on their efforts to identify fresh biomarkers of illness as well as more sensitive clinical assessment programs to identify those at risk for AD, to predict progression, and assess the effectiveness of fresh treatments. The future of clinical trials may lie in revisiting all drugs known to be secure and evaluate their relevance in AD treatment. We know of the importance of non-pharmaceutical trials and that anti-amyloid treatment for AD could start early on in the illness process. Furthermore we also learned more of other pathway with Tau Biomarkers, and their implications for AD along with combination therapeutics and phase 3 clinical trials results. Once more in 2019 Clinical squads will show their population studies on topics in the early scene of the illness or even at the asymptomatic stage. CTAD 2019 will highlight the recent on trying to receive these trials off the ground. Overall, the aim of the symposium is to overcome the hurdles and speed the development of effective treatments.